SCHEMBL2593679

SCHEMBL2593679

Cn1c(-c2ccccc2)c(P(=S)(c2ccccc2)c2ccccc2)c2ccccc21

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 9/20 0.66
HSD17B10 Q99714 3/20 0.54
CYP2C19 P33261 1/20 0.54
ALDH1A1 P00352 4/20 0.51
LMNA P02545 1/20 0.51
HPGD P15428 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.46
NPC1 O15118 1/20 0.46
MAPT P10636 1/20 0.46
HTT P42858 1/20 0.46
RAB9A P51151 1/20 0.46
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CYP11B2 P19099 1/20 0.44
GPR3 P46089 1/20 0.44
HK1 P19367 1/20 0.43
HKDC1 Q2TB90 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17403816 0.81 NPSR1 (0.51) NPSR1HSD17B10CYP2C19ALDH1A1LMNA
SCHEMBL2595693 0.79 NPSR1 (1.00) NPSR1HSD17B10CYP2C19ALDH1A1HPGD
SCHEMBL10067380 0.77 CYP11B2 (0.68) NPSR1HSD17B10CYP2C19ALDH1A1LMNA
SCHEMBL822744 0.73 ALDH1A1 (0.59) NPSR1HSD17B10CYP2C19ALDH1A1LMNA
SCHEMBL10529112 0.72 ALDH1A1 (0.58) NPSR1HSD17B10CYP2C19ALDH1A1LMNA
SCHEMBL29078839 0.72 ALDH1A1 (0.58) NPSR1HSD17B10CYP2C19ALDH1A1LMNA
SCHEMBL28186733 0.72 ALDH1A1 (0.57) NPSR1HSD17B10CYP2C19ALDH1A1LMNA
SCHEMBL4785226 0.72 ALDH1A1 (0.57) NPSR1HSD17B10CYP2C19ALDH1A1LMNA
SCHEMBL17403754 0.71 NPSR1 (0.52) NPSR1HSD17B10CYP2C19ALDH1A1LMNA
SCHEMBL10652634 0.69 ALDH1A1 (0.69) NPSR1HSD17B10CYP2C19ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011137220-A1 SMALL MOLECULE NEUROPEPTIDE S ANTAGONISTS FOR THE TREATMENT OF ADDICTIVE DISORDERS, MOOD, ANXIETY AND SLEEP DISORDERS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-11-03 WO disclosed
WO-2011137220-A1 SMALL MOLECULE NEUROPEPTIDE S ANTAGONISTS FOR THE TREATMENT OF ADDICTIVE DISORDERS, MOOD, ANXIETY AND SLEEP DISORDERS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-11-03 WO disclosed